Wiltschke C - Search Results

1

Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

Köstler WJ, Steger GG, Soleiman A, Schwab B, Singer CF, Tomek S, Brodowicz T, Krainer M, Wiltschke C, Horvat R, Jakesz R, Zielinski CC. Köstler WJ, et al. Among authors: wiltschke c. Anticancer Res. 2004 Mar-Apr;24(2C):1127-30. Anticancer Res. 2004. PMID: 15154635 Free article.

2

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.

Köstler WJ, Schwab B, Singer CF, Neumann R, Rücklinger E, Brodowicz T, Tomek S, Niedermayr M, Hejna M, Steger GG, Krainer M, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: wiltschke c. Clin Cancer Res. 2004 Mar 1;10(5):1618-24. doi: 10.1158/1078-0432.ccr-0385-3. Clin Cancer Res. 2004. PMID: 15014012

3

Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experience.

Köstler WJ, Steger GG, Krainer M, Kornek GV, Locker GJ, Brodowicz T, Marosi C, Singer CF, Hudelist G, Rabitsch W, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: wiltschke c. Anticancer Drugs. 2005 Feb;16(2):185-90. doi: 10.1097/00001813-200502000-00010. Anticancer Drugs. 2005. PMID: 15655416

4

The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.

Köstler WJ, Brodowicz T, Hudelist G, Rudas M, Horvat R, Steger GG, Singer CF, Attems J, Rabitsch W, Fakhrai N, Elandt K, Wiltschke C, Hejna M, Zielinski CC. Köstler WJ, et al. Among authors: wiltschke c. J Cancer Res Clin Oncol. 2005 Jul;131(7):420-8. doi: 10.1007/s00432-005-0670-3. Epub 2005 Apr 29. J Cancer Res Clin Oncol. 2005. PMID: 15864644

5

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro.

Brodowicz T, Wiltschke C, Budinsky AC, Krainer M, Steger GG, Zielinski CC. Brodowicz T, et al. Among authors: wiltschke c. Int J Cancer. 1997 Dec 10;73(6):875-9. doi: 10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3. Int J Cancer. 1997. PMID: 9399669 Free article.

6

Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.

Jasinska J, Wagner S, Radauer C, Sedivy R, Brodowicz T, Wiltschke C, Breiteneder H, Pehamberger H, Scheiner O, Wiedermann U, Zielinski CC. Jasinska J, et al. Among authors: wiltschke c. Int J Cancer. 2003 Dec 20;107(6):976-83. doi: 10.1002/ijc.11485. Int J Cancer. 2003. PMID: 14601058 Free article.

7

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer.

Bartsch R, De Vries C, Pluschnig U, Dubsky P, Bago-Horvath Z, Gampenrieder SP, Rudas M, Mader RM, Rottenfusser A, Wiltschke C, Gnant M, Zielinski CC, Steger GG. Bartsch R, et al. Among authors: wiltschke c. BMC Cancer. 2009 Oct 17;9:367. doi: 10.1186/1471-2407-9-367. BMC Cancer. 2009. PMID: 19835621 Free PMC article.

8

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Berghoff AS, Bago-Horvath Z, Dubsky P, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski CC, Bartsch R. Berghoff AS, et al. Among authors: wiltschke c. Breast J. 2013 Mar-Apr;19(2):149-55. doi: 10.1111/tbj.12070. Epub 2013 Jan 27. Breast J. 2013. PMID: 23350584 Clinical Trial.

9

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.

Köstler WJ, Brodowicz T, Attems Y, Hejna M, Tomek S, Amann G, Fiebiger WC, Wiltschke CH, Krainer M, Zielinski CC. Köstler WJ, et al. Among authors: wiltschke ch. Ann Oncol. 2001 Sep;12(9):1281-8. doi: 10.1023/a:1012272007146. Ann Oncol. 2001. PMID: 11697841 Free article. Clinical Trial.

10

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Among authors: wiltschke c. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page